arrow
Return

Improved Criterion for Assessing Lung Function Reversibility

delete2015-10-01
delete42
PRE
AI
H
Helen Ward
B
Brendan Cooper
M
Martin R. Miller *
DOI:10.1378/chest.14-2413delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
BACKGROUND: Consensus on how best to express bronchodilator reversibility (BDR) is lacking. We tested different BDR criteria against the null hypotheses that BDR should show no sex or size bias. To determine the best criterion for defining BDR, we hypothesized that clinically important BDR should be associated with better survival in respiratory patients compared with that of patients without BDR. METHODS: We used the first BDR test of 4,231 patients who had known subsequent survival status (50.8% male sex; mean age, 60.9 years; mean survival, 5.2 years [range, 0.1-16.5 years]). BDR for FEV 1 was expressed as absolute change, % baseline change, and change as % predicted FEV 1. RESULTS: Having BDR defined from absolute change was biased toward men (male to female ratio, 2.70) and toward those with larger baseline FEV 1. BDR defined by % change from baseline was biased toward those with lower baseline values. BDR defined by % predicted had no sex or size bias. Multivariate Cox regression found those with FEV 1 BDR. 8% predicted (33% of the subjects) had an optimal survival advantage (hazard ratio, 0.56; 95% CI, 0.45-0.69) compared with those with FEV 1 BDR <= 8% predicted. The survival of those with FEV 1 BDR. 8% predicted was not significantly different from that of those with FEV 1 BDR. 14% predicted but was significantly better than that of those with FEV 1 BDR, 0. CONCLUSIONS: We have shown that expressing FEV 1 BDR as % predicted avoids sex and size bias. FEV 1 BDR. 8% predicted showed optimal survival advantage and may be the most appropriate criterion to define clinically important reversibility.
Keywords:
SHORT-TERM VARIABILITY
BRONCHODILATOR REVERSIBILITY
GENDER-DIFFERENCES
GENERAL-POPULATION
PREVALENCE
ASTHMA
RESPONSIVENESS
DIAGNOSIS
SMOKING
FEV1
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Chest cover
Chest
IF:
8.6
Papers:
4.9W
Citations:
5.1W

Organization

U
University of Birmingham
Scholars:
4.1W
Papers: 3.8W
Citations: 5.0W
Cited Papers

Cited Papers

Biological effects monitoring in marine research
err2012-01-09
err0
errOAAI
errUlrike Kammann; Thomas Lang; Werner Wosniok
errShare
errSave
Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study
errTHORAX
IF7.7
err2012-04-29
err64
errOAAI
errTan, Wan C.; Vollmer, William M.; Lamprecht, Bernd; Mannino, David M.; Jithoo, Anamika; Nizankowska-Mogilnicka, Ewa; Mejza, Filip; Gislason, Thorarinn; Burney, Peter G. J.; Buist, A. Sonia
errShare
errSave
Enhanced Electrochemical Detection of Nitrite and Nitrite at a Cu-30Ni Alloy Electrode
err2011-06-01
err0
PREAI
errMatthew J. Moorcroft; Lembit Nei; James Davis; Richard G. Compton
errShare
errSave
Bronchodilator reversibility testing in chronic obstructive pulmonary disease
errTHORAX
IF7.7
err2003-08-01
err364
errOAAI
errCalverley, PMA; Burge, PS; Spencer, S; Anderson, JA; Jones, PW
errShare
errSave
Gender differences in asthma prevalence: Variations with socioeconomic disadvantage
err2009-12-27
err17
PREAI
errChittleborough, Catherine R.; Taylor, Anne W.; Dal Grande, Eleonora; Gill, Tiffany K.; Grant, Janet F.; Adams, Robert J.; Wilson, David H.; Ruffin, Richard E.
errShare
errSave
Improved survival prediction from lung function data in a large population sample
err2009-03-01
err40
errOAAI
errMiller, Martin R.; Pedersen, Ole F.; Lange, Peter; Vestbo, Jorgen
errShare
errSave
Plant Uptake of Xenobiotics
err2010-10-13
err0
PREAI
errChris D. Collins; Ian Martin; William Doucette
errShare
errSave
researcher View more